# aTYR PHARMA INC: Form 8-K, filed Oct 27, 2026

- Company: [aTYR PHARMA INC](/companies/atyr.md) (CIK 1339970)
- Form: 8-K
- Filed: 2026-10-27
- Accepted by EDGAR: Oct 27, 2026, 09:03 ET
- Period: 2026-10-27
- Accession: 0001339970-26-000071
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1339970/000133997026000071/atyr-20261027.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1339970/000133997026000071/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1339970/000133997026000071/atyr-20261027.htm

Filed Oct 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001339970-26-000071. Last ingested by Listed: Nov 6, 2026, 16:47 ET. No prices; not investment advice.